Publications (26) MARÍA LUISA SAYALERO MARINERO publications

filter_list

2014

  1. Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 955-956, Núm. 1, pp. 93-97

2012

  1. Cell-based drug-delivery platforms

    Therapeutic Delivery, Vol. 3, Núm. 1, pp. 25-41

2011

  1. Desarrollo y aplicación de recursos audiovisuales docentes en el área de farmacia y tecnología farmacéutica

    Primeras Jornadas de Innovación Docente en la Universidad de Salamanca

2008

  1. Solubility and release of fenamates intercalated in layered double hydroxides

    Clay Minerals, Vol. 43, Núm. 2, pp. 255-265

2006

  1. Cells and cell ghosts as drug carriers

    Nanoparticulates as Drug Carriers (Imperial College Press), pp. 329-348

2005

  1. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes

    Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, Vol. 12, Núm. 6, pp. 409-416

2004

  1. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis

    Blood Cells, Molecules, and Diseases, Vol. 33, Núm. 2, pp. 132-140

2003

  1. Encapsulación de amicacina en eritrocitos utilizando un método de diálisis hipoosmótica

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 113-116

2002

  1. Determination of Amikacin in biological tissues by HPLC

    Journal of Liquid Chromatography and Related Technologies, Vol. 25, Núm. 2, pp. 287-297

  2. Pharmacokinetic/pharmacodynamic modelling of ciprofloxacin 250 mg/12 h versus 500 mg/24 h for urinary infections

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. 1, pp. 67-72

  3. Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients

    Clinical Pharmacokinetics, Vol. 41, Núm. 14, pp. 1213-1220

2001

  1. Determination of ambroxol hydrochloride by HPLC

    Journal of Liquid Chromatography and Related Technologies, Vol. 24, Núm. 7, pp. 1007-1014

  2. Estudio por calorimetría diferencial de barrido (DSC) de la compatibilidad entre los componentes de una formulación oral líquida para administración oral

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 91, pp. 107-111

1999

  1. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues

    Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 721, Núm. 2, pp. 271-278

  2. In vitro study of the interaction between quinolones and polyvalent cations

    Pharmaceutica Acta Helvetiae, Vol. 73, Núm. 5, pp. 237-245

1995

  1. Calculation of partial components of bioavailability in slow release formulations using model-independent methods

    International Journal of Pharmaceutics, Vol. 117, Núm. 1, pp. 113-118

1992

  1. A Computer Program (DCN) for Numerical Convolution and Deconvolution of Pharmacokinetic Functions

    Journal of Pharmacobio-Dynamics, Vol. 15, Núm. 5, pp. 203-214

  2. A method for the calculation of bioavailability in slow release formulations in the presence of within-individual variability

    International Journal of Pharmaceutics, Vol. 86, Núm. 2-3, pp. 123-130

1991

  1. Bioequivalence of a new formulation of flecainide acetate.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 216-220

1989

  1. Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 2, pp. 169-175